Financials

  • Market Capitalization 3.82 B
  • Employee 1 184
  • Founded 2015
  • CEO Christian Behrenbruch
  • Website www.telixpharma.com
  • Headquarter Australia
  • FIGI BBG01N69K900
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Deuda total
Flujo de caja libre
Efectivo y equivalentes

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1474
RLAY
Relay Therapeutics, Inc. - Common Stock
17.98 USD+0.56%-7.79%-5.12%+193.79%3.94 B USD
1482
ABCL
AbCellera Biologics Inc. - Common Shares
12.64 USD+0.72%-9.71%+18.46%+128.99%3.88 B USD
1545
VCYT
Veracyte, Inc. - Common Stock
44.02 USD-2.68%-8.27%+7.16%+19.30%3.54 B USD
1560
IDYA
IDEAYA Biosciences, Inc. - Common Stock
36.06 USD-0.14%-5.68%-6.34%+10.68%3.48 B USD